AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer

被引:467
作者
Vasudevan, Krishna M. [1 ,2 ,3 ]
Barbie, David A. [1 ,5 ,12 ]
Davies, Michael A. [7 ]
Rabinovsky, Rosalia [1 ,2 ,3 ]
McNear, Chontelle J. [1 ,2 ]
Kim, Jessica J. [1 ,2 ]
Hennessy, Bryan T. [7 ]
Tseng, Hsiuyi [1 ]
Pochanard, Panisa [1 ]
Kim, So Young [1 ,2 ,5 ]
Dunn, Ian F. [1 ,2 ,3 ,4 ,5 ]
Schinzel, Anna C. [1 ,2 ,5 ]
Sandy, Peter [8 ]
Hoersch, Sebastian [8 ]
Sheng, Qing [1 ,3 ,4 ]
Gupta, Piyush B. [5 ]
Boehm, Jesse S. [5 ]
Reiling, Jan H. [9 ]
Silver, Serena [5 ]
Lu, Yiling [7 ]
Stemke-Hale, Katherine [7 ]
Dutta, Bhaskar [7 ]
Joy, Corwin [7 ]
Sahin, Aysegul A. [7 ]
Gonzalez-Angulo, Ana Maria [7 ]
Lluch, Ana [10 ]
Rameh, Lucia E. [11 ]
Jacks, Tyler [8 ]
Root, David E. [5 ]
Lander, Eric S. [5 ]
Mills, Gordon B. [7 ]
Hahn, William C. [1 ,2 ,3 ,4 ,5 ]
Sellers, William R. [1 ,6 ]
Garraway, Levi A. [1 ,2 ,3 ,5 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA
[5] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA
[6] Novartis Inst BioMed Res, Cambridge, MA 02139 USA
[7] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
[8] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[9] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA
[10] Univ Valencia, Clin Hosp, Valencia 46010, Spain
[11] Boston Biomed Res Inst, Watertown, MA 02472 USA
[12] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
基金
美国国家卫生研究院;
关键词
3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; MAMMARY EPITHELIAL-CELLS; HYDROPHOBIC MOTIF PHOSPHORYLATION; BREAST-CANCER; PHOSPHATIDYLINOSITOL; 3-KINASES; CAENORHABDITIS-ELEGANS; HOMOLOGY DOMAIN; HIGH-FREQUENCY; MTOR COMPLEX; ACTIVATION;
D O I
10.1016/j.ccr.2009.04.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dysregulation of the phosphatidylinositol 3-kinase (PI3K) signaling pathway occurs frequently in human cancer. PTEN tumor suppressor or PIK3CA oncogene mutations both direct PI3K-dependent tumorigenesis largely through activation of the AKT/PKB kinase. However, here we show through phosphoprotein profiling and functional genomic studies that many PIK3CA mutant cancer cell lines and human breast tumors exhibit only minimal AKT activation and a diminished reliance on AKT for anchorage-independent growth. Instead, these cells retain robust PDK1 activation and membrane localization and exhibit dependency on the PDK1 substrate SGK3. SGK3 undergoes PI3K- and PDK1-dependent activation in PIK3CA mutant cancer cells. Thus, PI3K may promote cancer through both AKT-dependent and AKT-independent mechanisms. Knowledge of differential PI3K/PDK1 signaling could inform rational therapeutics in cancers harboring PIK3CA mutations.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 56 条
[1]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[2]   Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas [J].
Barbareschi, Mattia ;
Buttitta, Fiamma ;
Felicioni, Lara ;
Cotrupi, Sabrina ;
Barassi, Fabio ;
Del Grammastro, Maela ;
Ferro, Antonella ;
Palma, Paolo Dalla ;
Galligioni, Enzo ;
Marchetti, Antonio .
CLINICAL CANCER RESEARCH, 2007, 13 (20) :6064-6069
[3]   Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice [J].
Bayascas, JR ;
Leslie, NR ;
Parsons, R ;
Fleming, S ;
Alessi, DR .
CURRENT BIOLOGY, 2005, 15 (20) :1839-1846
[4]   Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent [J].
Blend, MJ ;
Stastny, JJ ;
Swanson, SM ;
Brechbiel, MW .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2003, 18 (03) :355-363
[5]   Integrative genomic approaches identify IKBKE as a breast cancer oncogene [J].
Boehm, Jesse S. ;
Zhao, Jean J. ;
Yao, Jun ;
Kim, So Young ;
Firestein, Ron ;
Dunn, Ian F. ;
Sjostrom, Sarah K. ;
Garraway, Levi A. ;
Weremowicz, Stanislawa ;
Richardson, Andrea L. ;
Greulich, Heidi ;
Stewart, Carly J. ;
Mulvey, Laura A. ;
Shen, Rhine R. ;
Ambrogio, Lauren ;
Hirozane-Kishikawa, Tomoko ;
Hill, David E. ;
Vidal, Marc ;
Meyerson, Matthew ;
Grenier, Jennifer K. ;
Hinkle, Greg ;
Root, David E. ;
Roberts, Thomas M. ;
Lander, Eric S. ;
Polyak, Kornelia ;
Hahn, William C. .
CELL, 2007, 129 (06) :1065-1079
[6]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[7]   A transforming mutation in the pleckstrin homology domain of AKT1 in cancer [J].
Carpten, John D. ;
Faber, Andrew L. ;
Horn, Candice ;
Donoho, Gregory P. ;
Briggs, Stephen L. ;
Robbins, Christiane M. ;
Hostetter, Galen ;
Boguslawski, Sophie ;
Moses, Tracy Y. ;
Savage, Stephanie ;
Uhlik, Mark ;
Lin, Aimin ;
Du, Jian ;
Qian, Yue-Wei ;
Zeckner, Douglas J. ;
Tucker-Kellogg, Greg ;
Touchman, Jeffrey ;
Patel, Ketan ;
Mousses, Spyro ;
Bittner, Michael ;
Schevitz, Richard ;
Lai, Mei-Huei T. ;
Blanchard, Kerry L. ;
Thomas, James E. .
NATURE, 2007, 448 (7152) :439-U1
[8]   Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1:: identification of five sites of phosphorylation in vivo [J].
Casamayor, A ;
Morrice, NA ;
Alessi, DR .
BIOCHEMICAL JOURNAL, 1999, 342 :287-292
[9]   Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1 [J].
Currie, RA ;
Walker, KS ;
Gray, A ;
Deak, M ;
Casamayor, A ;
Downes, CP ;
Cohen, P ;
Alessi, DR ;
Lucocq, J .
BIOCHEMICAL JOURNAL, 1999, 337 :575-583
[10]   Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer [J].
Depowski, PL ;
Rosenthal, SI ;
Ross, JS .
MODERN PATHOLOGY, 2001, 14 (07) :672-676